Overview

Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Safety study to assess the 3 mg/mL baclofen injection (intrathecal) using a programmable pump
Phase:
Phase 3
Details
Lead Sponsor:
Mallinckrodt
Piramal Critical Care, Ltd.
Treatments:
Baclofen